Related Experiment Videos
The reduced graph descriptor in virtual screening and data-driven clustering of high-throughput screening data
G Harper1, G S Bravi, S D Pickett
1GlaxoSmithKline, Gunnels Wood Road, Stevenage SG1 2NY, United Kingdom. gavin.x.harper@gsk.com
Summary
This study enhances virtual screening methods using reduced graphs for drug discovery. A novel data-driven clustering approach improves high-throughput screening data analysis, identifying promising drug candidates more effectively.
Area of Science:
- Computational chemistry
- Cheminformatics
- Drug discovery
Background:
- Virtual screening and high-throughput screening are crucial for identifying drug leads.
- Existing methods for reduced graph similarity searching have limitations, particularly in representing molecular features.
Purpose of the Study:
- To improve similarity searching methods for ligand-based virtual screening using reduced graphs.
- To introduce a novel application of reduced graphs for clustering high-throughput screening data.
Main Methods:
- Extended the definition of reduced graphs to include ionizable groups.
- Developed a new similarity measure based on weighted edit distance for reduced graphs.
- Implemented a database system for iterative querying with multiple molecular representations.
Main Results:
- Introduced a novel data-driven clustering method for high-throughput screening data using reduced graphs.
- Demonstrated more flexible query capabilities beyond simple similarity searching.
- Showcased the utility of reduced graphs in capturing ligand-receptor interaction features.
Conclusions:
- Reduced graphs offer an informative approach to analyzing high-throughput screening data.
- The new methods enhance lead discovery by improving similarity searching and data clustering.
- Data-driven clustering effectively identifies clusters of active compounds from screening data.